Sony’s goal with these new devices is to break down the current barriers faced by those with signs of mild to moderate hearing loss and provide a simple, app-enabled, do-it-yourself solution.
The CRE-C10 self-fitting OTC hearing aid has a suggested retail price of $999.99 and will be available for sale this month.
The CRE-E10 self-fitting OTC hearing aid will be available this winter at the suggested price of $1,299.99.
Price Action: SONY shares are trading lower by 1.19% at $63.40 on the last check Wednesday.
